Title |
Understanding the Impact of Hazardous and Harmful Use of Alcohol and/or Other Drugs on ARV Adherence and Disease Progression
|
---|---|
Published in |
PLOS ONE, May 2015
|
DOI | 10.1371/journal.pone.0125088 |
Pubmed ID | |
Authors |
Rehana Kader, Rajen Govender, Soraya Seedat, John Randy Koch, Charles Parry |
Abstract |
The objective of this study was to understand the impact of hazardous and harmful use of alcohol and/or other drugs on ARV adherence and disease progression among HIV patients. A cross-sectional study design was used. A total of 1503 patients attending HIV clinics in Cape Town, South Africa were screened for problematic substance use. A sub-sample of 607 patients (303 patients who screened positive for problematic substance use and 304 who did not) participated in this study. Hazardous or harmful alcohol use and problematic drug use predicted missing and stopping ARVs which, in turn, was associated with a decrease in CD4 counts and more rapid HIV-disease progression and poorer health outcomes in people living with HIV/AIDS (PLWHA). The findings of this study underscore the need for an integrated approach to managing substance-use disorders in PLWHA. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
South Africa | 1 | 1% |
Unknown | 98 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 17 | 17% |
Student > Postgraduate | 13 | 13% |
Researcher | 12 | 12% |
Student > Ph. D. Student | 9 | 9% |
Student > Doctoral Student | 8 | 8% |
Other | 22 | 22% |
Unknown | 19 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 27 | 27% |
Nursing and Health Professions | 14 | 14% |
Social Sciences | 10 | 10% |
Psychology | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Other | 14 | 14% |
Unknown | 22 | 22% |